Kiniksa Pharmaceuticals International, plc (KNSA) › Net IncomeKiniksa Pharmaceuticals International, plc (KNSA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$64.87M2018: -$103.23M2019: -$161.87M2020: -$161.38M2021: -$157.92M2022: $183.36M2023: $14.08M2024: -$43.19M2025: $59.01M$59.01M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$59.01M+236.6%2024-$43.19M-406.7%2023$14.08M-92.3%2022$183.36M+216.1%2021-$157.92M+2.1%2020-$161.38M+0.3%2019-$161.87M-56.8%2018-$103.23M-59.1%2017-$64.87M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share